CODEXIS INC. - COMMON STOCK
4.1000
13-February-25 15:45:00
15 minutes delayed
Stocks
-0.0200
-0.49%
Today's range
4.0350 - 4.2400
ISIN
N/A
Source
NASDAQ
-
01 Oct 2024 06:05:47 By Nasdaq GlobeNewswire
-
Codexis Announces New Employment Inducement Grants
06 Sep 2024 15:05:08 By Nasdaq GlobeNewswire
-
Codexis to Participate in Upcoming Healthcare Conferences
03 Sep 2024 15:05:58 By Nasdaq GlobeNewswire
-
Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting
20 Aug 2024 15:05:36 By Nasdaq GlobeNewswire
-
Codexis Announces New Employment Inducement Grants
16 Aug 2024 15:05:09 By Nasdaq GlobeNewswire
-
Codexis Publishes FY2023 Sustainability Disclosures
15 Aug 2024 15:05:22 By Nasdaq GlobeNewswire
-
Codexis Reports Second Quarter 2024 Financial Results
08 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
Codexis to Report Second Quarter 2024 Financial Results on August 8
18 Jul 2024 15:05:11 By Nasdaq GlobeNewswire
-
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets
01 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
Codexis to Participate in Jefferies Global Healthcare Conference
22 May 2024 15:25:41 By Nasdaq GlobeNewswire
-
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
20 May 2024 15:05:14 By Nasdaq GlobeNewswire
-
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
14 May 2024 05:00:00 By Nasdaq GlobeNewswire
-
Codexis Reports First Quarter 2024 Financial Results
02 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
Codexis to Report First Quarter 2024 Financial Results on May 2
18 Apr 2024 15:05:10 By Nasdaq GlobeNewswire
-
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
11 Apr 2024 06:05:13 By Nasdaq GlobeNewswire
-
Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
28 Feb 2024 15:05:01 By Nasdaq GlobeNewswire
-
26 Feb 2024 15:05:42 By Nasdaq GlobeNewswire
-
Codexis to Participate in TD Cowen 44th Annual Health Care Conference
26 Feb 2024 07:05:47 By Nasdaq GlobeNewswire
-
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
20 Feb 2024 07:05:01 By Nasdaq GlobeNewswire
-
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28
14 Feb 2024 15:05:29 By Nasdaq GlobeNewswire